Analystreport

Ekso Bionics (NASDAQ:EKSO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Ekso Bionics Holdings, Inc.  (EKSO) 
NASDAQ:AMEX Investor Relations: ir.eksobionics.com